# Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

> **NCT02578277** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 59 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** CYP and transporter probe substrates
- **DRUG:** BMS-955176
- **DRUG:** BMS-955176 plus CYP and transporter probe substrates

## Key facts

- **NCT ID:** NCT02578277
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-09
- **Primary completion:** 2015-12-23
- **Final completion:** 2015-12-23
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2018-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578277, "Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02578277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*